Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca completes transaction for majority equity stake investment in Acerta Pharma
-
Lynparza™ (olaparib) granted Breakthrough Therapy designation by US FDA for treatment of BRCA1/2 or ATM gene mutated metastatic Castration Resistant Prostate Cancer
-
AstraZeneca partners with peers and academia to establish translational research fund
-
AstraZeneca and Incyte announce new lung cancer clinical trial collaboration
-
AstraZeneca and Moderna Therapeutics announce new collaboration to co-develop and co-commercialise immuno-oncology mRNA therapeutics™
-
ZURAMPIC® (lesinurad) approved by US FDA for patients with gout
-
BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack
-
TAGRISSO™ (osimertinib) receives positive CHMP opinion for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer
-
CHMP issues positive opinion on lesinurad for Gout
-
Durvalumab ATLANTIC trial supports clinical activity and AstraZeneca’s overall immuno-oncology strategy
Latest articles and press releases
All of our latest press releases and articles are available to explore
